Sea Limited (SE) fell about 5.2% on October 19, 2026, to $88.92 in early trading. That extends a slide that has taken the stock 14.2% below its September 22 close of $103.67. Nothing in the news record explains the drop, and it came while the market and the consumer sector were rising. The balance of evidence for the next 2 to 6 weeks leans negative, with high conviction (3 of 4 points). Oversold history is the main counterweight.
Why it matters
There is no event to point to. The company-announcement headlines in the record concern other issuers: Halozyme and Axon convertible note pricings, a PBF Energy exchangeable offering, an auditor change at Sivers Semiconductors. None mentions SE. The debate pieces are about Nvidia's buyback, Meta's AI assistant and Coca-Cola's valuation. A 5% one-day fall with no disclosed catalyst looks more like holders selling than a new fact reaching the market. The record cannot confirm that, and it should not be dressed up as a story it does not support.
The drop also arrives after a long decline. SE is down 12.6% over one month and 30.3% so far this year, while the S&P 500 is up 12.5% and the consumer discretionary ETF XLY is down 5.3%. The stock sits 46.3% below its 52-week high of $165.70. It is under both the 50-day average at $107.23 and the 200-day average at $101.22. Today's fall looks like a continuation of that trend.
The five-day numbers show how much of the move belongs to the stock itself. SE is down 7.3% over five days. SPY fell 1.4% and XLY rose 0.7%, so the stock trailed its sector by 8.0 points. The market explains little of this and the sector explains none. Over 50 days SE lags the S&P 500 by 17.0 points and XLY by 16.5 points. This is a stock-specific problem, not a sector one.
The disagreement over SE shows up in the analyst numbers rather than in any article. Of 28 analysts, the consensus is strong buy, with a mean price target of $154.93, a low of $105 and a high of $195. The lowest target is above today's price and above the September 22 peak close. The price sits 42.6% below the mean target. The optimistic side is saying the business is worth far more than the stock. The tape says the opposite, and price targets tend to trail a falling stock. A gap this wide has not triggered buying.
What the evidence says
On the long term, the thesis is weakened and drifting toward broken. The stock is below its 40-week and 10-week averages, so the weekly trend is down. It is 46% off its high and 13.8% above the 52-week low of $78.16. The phase is a failed rebound inside a downtrend: the stock peaked on September 22 and has given back 14.2% since. A weekly close above $97.69 is the line between a weakened trend and a repaired one.
For the next 2 to 6 weeks, the balance of evidence leans negative. Conviction is high, at 3 of 4 points. The daily trend runs with the weekly downtrend, so the two timeframes agree. The stock also lags the S&P 500 by 17.0% and XLY by 16.5% over 50 days. Sellers are in control on both trend and relative strength.
The strongest case against this reading is that the stock is stretched. RSI is 29.3, which is oversold. After one-day drops of more than 5%, shares were higher a month later 70.9% of the time across 151 cases, against 61.8% typically, with a median gain of 5.4%. A rebound is a real possibility, and this is why conviction is not higher. It does not tip the balance, because the other oversold signal shows no edge. After RSI fell below 30, shares were higher a month later 61.4% of the time across 303 cases, no better than the 61.8% typical. The median gain was 2.2%. A bounce would also have to climb through $90 and $92.82, where sellers have appeared before, while the weekly trend points down. Volume is 77% below its 20-day average, but the session is young, so that says little.
Levels that matter
The structure holds below $90.00, a round number where sellers have shown up on rallies. Above it, $92.82 is the next resistance. The weekly downtrend ends only on a weekly close above $97.69, a swing zone. Beyond that sit $100 and the 200-day average at $101.22. Until then, rallies run into overhead supply.
The breakout level is a daily close below $85.15. From there the first target is $81.51, a swing zone, which gives 0.6 to 1 against a stop at $90.81. That stop is $90 plus a quarter of the 14-day ATR. The second target is the 52-week low at $78.16, which gives 1.2 to 1. The math does not reach the 3 to 1 that makes a breakout worth the risk. It would take a target well below the 52-week low, with $70 the next listed support, or a much tighter stop. The round $80 sits between the two targets.
What would change the picture
The rule is a weekly close above $97.69. That would put the stock back above the swing zone that capped the September rebound and begin repairing the weekly trend. The non-price fact that could do it is the earnings report on November 10, 2026, if it shows growth intact and accounts for this selloff. Without an explanation from the company, the drop remains unexplained and the price action stays the evidence.
What to watch
- Earnings, November 10, 2026: the number that matters is revenue growth against what the market expects, since that is the likeliest explanation for a drop with no stated cause.
- Sector: XLY is up 1.8% over one month. SE has fallen while the sector rose, so a turn down in XLY would add pressure before any SE news. The next test is whether the stock can reclaim $90.00 or loses $85.15.
- Valuation: the stock trades 42.6% below the $154.93 mean target, and the lowest of 28 targets is $105. Consensus has not changed its mind. The price has.